Australian oncology-focused oncology company Kazia Therapeutics has entered an agreement with QIMR Berghofer Medical Research Institute covering several investigative drug candidates.
Australian company Kazia executes licensing agreement with QIMR Berghofer
September 16, 2024 Latest NewsAustralian BiotechLatest Video
New Stories
-
Clear political leadership delivers green shoots in New Zealand
September 18, 2024 - - Latest News -
AusBiotech pays tribute to a leading figure in the creation of Australia's biotech sector
September 18, 2024 - - Latest News -
Pharmac continues to invest its post-Budget funding boost
September 18, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number four of five
September 18, 2024 - - Latest News -
Wesfarmers Health announces plan to build new fulfilment centre in Cairns
September 17, 2024 - - Latest News -
Medicines Australia launches next phase of campaign in PM's electorate
September 17, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number three of five
September 17, 2024 - - Latest News